Shandong Jincheng Pharmaceutical Group Co., Ltd (SHE:300233)

SHE:300233 Revenue

Shandong Jincheng Pharmaceutical Group had revenue of 582.25M CNY in the quarter ending September 30, 2026, with 1.83% growth. This brings the company's total for the last twelve months to 2.83B, up 1.59% year-over-year. In the year 2025, Shandong Jincheng Pharmaceutical Group had annual revenue of 2.74B, down -18.87%. That makes Shandong Jincheng Pharmaceutical Group the 12,241st largest company in the world by revenue and 2,111th in China.

• Revenue (ttm): 2.83B
• Revenue Growth: +1.59%
• P/S Ratio: 1.54
• Revenue / Employee: 806.37K
• Employees: 3,515
• Market Cap: 4.35B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Intermediates Division 1.30B 46.6%
• Formulation Division 942.00M 33.7%
• Specialty APIs 519.85M 18.6%
• Others 30.57M 1.1%

By Geography

Chart

• China 2.27B 82.9%
• Foreign 466.80M 17.1%

Fiscal year ended Dec 31, 2025 See the full SHE:300233 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.74B	-636.46M	-18.87%
Dec 31, 2024	3.37B	-164.93M	-4.66%
Dec 31, 2023	3.54B	32.60M	0.93%
Jan 1, 2023	3.51B	367.26M	11.70%
Jan 1, 2022	3.14B	176.52M	5.96%

Data Source: S&P Global Market Intelligence Last updated: Oct 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error